Highlights bioAffinity Technologies, Inc.

Equities

BIAF

US09076W1099

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
2.53 ^USD	+6.75%		-15.67%	+72.05%

Apr. 01	BioAffinity Technologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 20	BioAffinity Technologies, Inc. announced that it has received $2.624 million in funding	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BioAffinity Technologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 01	CI
Earnings Flash (BIAF) BIOAFFINITY TECHNOLOGIES Posts Q3 Revenue $298,484	Nov. 14	MT
BioAffinity Technologies, Inc. Provides Earnings Guidance for the Year 2023 and for the Next 12 Months(fourth quarter 2023 to third quarter 2024)	Nov. 14	CI
BioAffinity Technologies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
BioAffinity Technologies Unit Acquires Precision Pathology Services Laboratory Assets; Shares Rise	23-09-19	MT
Earnings Flash (BIAF) BIOAFFINITY TECHNOLOGIES Reports Q2 Revenue $19,738	23-08-14	MT
BioAffinity Technologies, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
AMA Issues CPT Code for bioAffinity Technologiesâ€™ CyPathÂ® Lung Test for Early-Stage Lung Cancer	23-07-12	CI
BioAffinity Technologies, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Earnings Flash (BIAF) BIOAFFINITY TECHNOLOGIES Posts Q1 Revenue $921	23-05-15	MT
BioAffinity Technologies to Ring Nasdaq Closing Bell Today	23-04-05	BU
BioAffinity Technologies Reports Fourth Quarter and Full Year 2022 Financial Results	23-03-31	BU
BIOAFFINITY TECHNOLOGIES, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	23-03-31	AQ
BioAffinity Technologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-31	CI
BioAffinity Technologies Announces Publication of Peer-Reviewed Paper on Proprietary Beads Used in CyPath Lung for Noninvasive Detection of Early-Stage Lung Cancer	23-03-28	CI
BioAffinity Technologies, Inc. Announces Publication of Results of Clinical Trial in Peer-Reviewed Journal Respiratory Research	23-01-24	CI
Bioaffinity Technologies Announces Notice to Award U.S. Patent and Trademark Office Protecting Novel Compounds for Specific Delivery of Cancer Treatments	23-01-04	CI
BIOAFFINITY TECHNOLOGIES, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	22-11-14	AQ
BioAffinity Technologies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
BioAffinity Technologies Reports Third Quarter 2022 Financial Results and Provides Business Update	22-11-14	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights bioAffinity Technologies, Inc.

Equities

BIAF

US09076W1099

Highlights

Filters